Abstract:Biomolecular interaction acts a pivotal part in understanding the mechanisms underlying the development of Alzheimer's disease (AD). Herein, we built a biosensing platform to explore the interaction between gelsolin (GSN) and different beta-amyloid protein 1-42 (A beta(1-42)) species, including A beta(1-42) monomer (m-A beta), A beta(1-42) oligomers with both low and high levels of aggregation (LLo-A beta and HLo-A beta) via dual polarization interferometry (DPI). Real-time molecular interaction process and kinetic analysis showed that m-A beta had the strongest affinity and specificity with GSN compared with LLo-A beta and HLo-A beta. The impact of GSN on inhibiting aggregation of A beta(1-42 )and solubilizing A beta(1-42) aggregates was evaluated by circular dichroism (CD) spectroscopy. The maintenance of random coil structure of m-A beta and the reversal of beta-sheet structure in HLo-A beta were observed, demonstrating the beneficial effects of GSN on preventing A beta from aggregation. In addition, the structure of m-A beta/GSN complex was analyzed in detail by molecular dynamics (MD) simulation and molecular docking. The specific binding sites and crucial intermolecular forces were identified, which are believed to stabilize m-A beta in its soluble state and to inhibit the fibrilization of A beta(1-42). Combined theoretical simulations and experiment results, we speculate that the success of GSN sequestration mechanism and the balance of GSN levels in cerebrospinal fluid and plasma of AD subjects may contribute to a delay in AD progression. This research not only unveils the molecular basis of the interaction between GSN and A beta(1-42), but also provides clues to understanding the crucial functions of GSN in AD and drives the development of AD drugs and therapeutic approaches.

A Method for Evaluating the Level of Soluble Β-Amyloid(1-40/1-42) in Alzheimer's Disease Based on the Binding of Gelsolin to Β-Amyloid Peptides.

Gelsolin bound β-amyloid peptides(1-40/1-42): electrochemical evaluation of levels of soluble peptide associated with Alzheimer's disease.

Salivary Aβ1–42 May Be a Quick-Tested Biomarker for Clinical Use in Alzheimer’s Disease: a Meta-Analysis

Electrochemical Immunosensor for the Sensitive Detection of Alzheimer’s Biomarker Amyloid‐β (1–42) Using the Heme‐amyloid‐β (1–42) Complex As the Signal Source

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Electrochemical Detection Of Beta-Amyloid Peptides On Electrode Covered With N-Terminus-Specific Antibody Based On Electrocatalytic O-2 Reduction By A Beta(1-16)-Heme-Modified Gold Nanoparticles

Competitive Electrochemical Immunoassay For Detection Of Beta-Amyloid (1-42) And Total P-Amyloid Peptides Using Beta-Aminophenol Redox Cycling

A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles.

Competitive electrochemical immunoassay for detection of β-amyloid (1-42) and total β-amyloid peptides using p-aminophenol redox cycling.

Gelsolin Encountering Ag Nanorods/Triangles: an Aggregation-Based Colorimetric Sensor Array for in Vivo Monitoring the Cerebrospinal Aβ42% As an Indicator of Cd2+ Exposure-Related Alzheimer’s Disease Pathogenesis

Regenerable and Simultaneous Surface Plasmon Resonance Detection of Aβ(1−40) and Aβ(1−42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific Antibody

Highly sensitive in-situ growth gold dendrite structure electrochemical sensor for early Alzheimer's disease screening

Electrochemical Detection of Amyloid-Β Oligomer with the Signal Amplification of Alkaline Phosphatase Plus Electrochemical–chemical–chemical Redox Cycling

A Hydrogel Biosensor for High Selective and Sensitive Detection of Amyloid-Beta Oligomers

Detection of Amyloid-β(1–42) Aggregation With a Nanostructured Electrochemical Sandwich Immunoassay Biosensor

Electrochemical Methods For Detecting Beta-Amyloid Peptides And Monitoring Their Aggregation

Real-time Analysis of the Biomolecular Interaction Between Gelsolin Andaβ1-42 Monomer and Its Implication for Alzheimer's Disease

Electrochemical Methods for Detecting Β-Amyloid Peptides and Monitoring Their Aggregation

Microbiosensor for Alzheimer's disease diagnostics: detection of amyloid beta biomarkers.

A Conformationally-Locked P-Hydroxybenzylidene Imidazolinone Derivative for Detecting Aβ42 Aggregation

Recent Advances in Electrochemical Biosensors for the Detection of Aβ42, a Biomarker for Alzheimer Disease Diagnosis